Bu içeriği görüntülemek için JoVE aboneliği gereklidir. Oturum açın veya ücretsiz deneme sürümünü başlatın.
Method Article
* Bu yazarlar eşit katkıda bulunmuştur
To study combined solid organ and vascularized composite allotransplantation, we describe a novel heterotopic en bloc chest wall, thymus, and heart transplant model in mice using a cervical non-suture cuff technique.
Exploration of novel strategies in organ transplantation to prolong allograft survival and minimizing the need for long-term maintenance immunosuppression must be pursued. Employing vascularized bone marrow transplantation and co-transplantation of the thymus have shown promise in this regard in various animal models.1-11 Vascularized bone marrow transplantation allows for the uninterrupted transfer of donor bone marrow cells within the preserved donor microenvironment, and the incorporation of thymus tissue with vascularized bone marrow transplantation has shown to increase T-cell chimerism ultimately playing a supportive role in the induction of immune regulation. The combination of solid organ and vascularized composite allotransplantation can uniquely combine these strategies in the form of a novel transplant model. Murine models serve as an excellent paradigm to explore the mechanisms of acute and chronic rejection, chimerism, and tolerance induction, thus providing the foundation to propagate superior allograft survival strategies for larger animal models and future clinical application. Herein, we developed a novel heterotopic en bloc chest wall, thymus, and heart transplant model in mice using a cervical non-suture cuff technique. The experience in syngeneic and allogeneic transplant settings is described for future broader immunological investigations via an instructional manuscript and video supplement.
Cardiac transplantation is the treatment of choice for end-stage heart failure. Both technical advancements and pharmacological innovations have propelled the field to early graft acceptance rates above 90%.12,13 Despite this, 60-80% 5-year graft survival is at a standstill and chronic rejection, characterized by transplant vasculopathy, remains inevitable.14-16 Furthermore, patients are subjected to multiple surgical procedures and lifelong immunosuppression, which are associated with chest wall deformities and medical sequelae and toxicities, respectively. The need for innovative approaches to extend allograft survival, minimize the immunosuppressive requirements, and offer reconstructive options for anatomical deformities is pressing.
Vascularized composite allotransplantation offers a unique strategy for improving heart transplant outcomes both from an immunological aspect as well as a reconstructive perspective.17 Vascularized composite allografts are also unique in a way that they have an inherent source of donor-derived hematopoietic stem cells which has shown a favorable ability to reduce immunosuppression and induce and sustain mixed chimerism.1-8 Additionally, co-transplantation of the thymus has shown to prolong survival of both, solid organ transplants and vascularized composite allografts.2,9-11 Combining these strategies with heart transplantation offers a novel solution to the aforementioned challenges facing heart transplantation.18
Murine models serve as excellent platforms for mechanistic in vivo investigation because of the availability of antibodies and well-defined inbred and knockout strains.19-21 Although heart transplantation in mice is commonly studied using a heterotopic intraabdominal microsurgical suture transplant model22-25, a heterotopic, cervical, non-suture cuff technique model has shown to be extremely replicable, reliable, and carries fewer rates of thrombosis.19,26,27 The goal of this study is to develop a heterotopic en bloc osteomyocutaneous chest wall, thymus, and heart transplant technique in mice to study the immunological mechanisms of combined solid organ and vascularized composite allotransplantation using a cervical non-suture cuff technique. This cluster allograft is perfused through the anastomosis of the donor descending aorta to the right common carotid artery and the donor pulmonary artery to the right external jugular vein. Preservation of the internal thoracic vessels and associated thymus branches is paramount to perfusing the chest wall (sternum, ribs, muscles, and skin) and thymus.
Tüm operatif prosedürler Johns Hopkins Üniversitesi'nde ve ABD Tarım Bakanlığı ve Halk Sağlığı Servisi gereklerine uygun olarak tamamlanmıştır. Bu protokol Johns Hopkins Üniversitesi Hayvan Bakım ve Kullanım Komitesi izler, kurumsal inceleme kurulu (protokol numarası M013M490) yönergeleri onayladı. Nihai sağkalım verileri aşağıda açıklanan cerrahi prosedürler için kaydedildi. Hem verici hem alıcı hayvanlar 0.1 mg buprenorfin kullanılarak rüçhan anestezisi / kg sc bir saat önce cerrahi ve alıcı hayvan buprenorfinin nakli sonrasında aynı dozda uygulanan yeniden ilk 48 saat içinde gerektiğinde yeniden dozlanır ameliyat sonrası.
1. Donör Allogreft Kurtarma
Not: Alıcı anestezi süresini en aza indirmek için erken alıcı nakli daha nakli 40 dakika donör bölümünü başlayın ve eşzamanlı bitiş saati veya biraz kulak kolaylaştırmak içinAlıcı hazırlık karşı lier bitiş zamanı.
2. Alıcı Hazırlık
Not: Alıcı anestezi süresini en aza indirmek için,Ayrı bir ameliyat istasyonunda önceki donör allogreft hasat tamamlanması yaklaşık 40 dakika alıcı hazırlık başlar.
3. Allogreft Ankastre
4. Ameliyat Sonrası Bakım
Singenik C57BL / 6 nakli uzun süreli yaşam elde etti. Allogreft (Şekil 1) tasarım bir hayvan hayatta kalma perspektifi ve sürekli allogreft hayatta değerlendirmek yeteneği başarılı olduğunu kanıtladı. Bu canlı, aktif devam eden allogreft saç büyümesini kalan örten deri yoluyla gösterilmiştir ve kalp atışları görselleştirme ve parmak palpasyonla değerlendirilecek başardık. Hayatta kalma verileri, ayni atadan gelme nakledilen farelerde, Şekil 2'de gösteri...
Dahil allotransplantasyon, immunolojik soruşturma içine faktör ama akut ve kronik rejeksiyon, doğrudan ve dolaylı antijen sunumu, alıcı duyarlılık ya da karışık kimerizmin indüksiyon mekanizmaları bunlarla sınırlı değildir fenomen çok sayıda bulunmaktadır. 19 hayvan modelleri haline gelmiştir transplant immünolojinin çalışma için altın standardı ve fare modelleri halk nedeniyle düşük bağıl veterinerlik ve konut taleplerini azalma maliyet transjenik ve gen knockout farelerde m...
The authors do not have any conflicts of interest or financial disclosures to declare.
This work was funded by the American Association of Plastic Surgeons 2014 Academic Scholar Award.
Name | Company | Catalog Number | Comments |
Euro-Collins Solution | The solution is not commercially purchased but rather prepared in the laboratory. To make a 500 ml solution add the ingredient listed below to a 330 ml of double distilled water. Mix well, and then fill in the rest of the 170 ml of double distilled water into the solution to a final volume of 500 ml. Ingredients: 1.02 g KH2PO4, 3.66 g K2HPO4, 0.56 g KCl, 0.42 g NaHCO3, and 17.52 g of glucose. | ||
Suture | Ethilon | MWI 72667 | 6-0 Ethilon https://www.mwivet.com (MWI - Veterinary Supplies) |
Polyimide Cuff Vein (21G) | Vention Medical | 141-0043 | http://www.ventionmedical.com/products-and-services/polyimide-tubing/ |
Polyimide Cuff Artery (24G) | Vention Medical | 141-0027 | http://www.ventionmedical.com/products-and-services/polyimide-tubing/ |
Soft plastic tip catheter | Terumo | SR*OX2419CA | 24G x 3/4" |
Microsurgical dilator | S&T | D-5a.1 | Dilator, 11 cm, FH, 0.1 mm AT10d |
Bu JoVE makalesinin metnini veya resimlerini yeniden kullanma izni talebi
Izin talebiThis article has been published
Video Coming Soon
JoVE Hakkında
Telif Hakkı © 2020 MyJove Corporation. Tüm hakları saklıdır